U.S. Professional Services Stock News

DXC Technology (NYSE:DXC) has entered a multi year partnership with ServiceNow to roll out ServiceNow’s new agentic AI tools across DXC’s core business operations. DXC will act as "Customer Zero" for ServiceNow’s Core Business Suite, using the platform internally before it is broadly offered to clients. The collaboration is aimed at deploying scalable AI led automation and more streamlined enterprise functions for DXC and its customers. For investors watching NYSE:DXC, this partnership...

If you are wondering whether Ultragenyx Pharmaceutical at US$23.15 is a bargain or a value trap, the key is understanding what the current price actually implies about the business. The stock has returned 8.1% over the last week and 2.4% over the last month, but is still showing a 1.9% decline year to date and a 31.7% decline over the last year, with even deeper 3 year and 5 year returns of 38.3% and 78.6% respectively. These moves sit against a backdrop of ongoing interest in rare disease...

Why PriceSmart's Latest Earnings Are Back in Focus PriceSmart (PSMT) is back on investors’ radar after reporting fiscal second quarter results that showed higher revenue and net income year over year, alongside plans for new clubs and supply chain upgrades across its markets. See our latest analysis for PriceSmart. The earnings release and club expansion plans appear to have coincided with stronger trading interest, with a 27.1% year to date share price return and an 84.5% one year total...

Rosen Law Firm has filed a class action lawsuit against Vital Farms over alleged misleading statements about risks and impacts tied to its new enterprise resource planning system rollout, claiming investors were harmed when delays contributed to missing full-year 2025 earnings guidance and consensus. The case brings Vital Farms’ disclosure practices and operational execution under legal scrutiny, raising questions about how accurately management communicated ERP-related risks and their...

Investors may be wondering whether Affiliated Managers Group at around US$286.48 is still offering value, or if most of the easy gains are already on the table. The stock has moved 4.7% over the last 7 days and 1.8% over the last 30 days, with a 79.3% return over 1 year, 106.1% over 3 years and 83.0% over 5 years, even though the year to date return sits at a slight 0.8% decline. Recent coverage has focused on how asset managers are positioning for changing investor preferences and capital...

If you are wondering whether American States Water at around US$77.09 is offering good value right now, it helps to separate the story from the numbers before making any decisions. The stock has posted returns of 1.2% over the last 7 days, 1.9% over 30 days, 6.7% year to date, 5.4% over 1 year, an 11.3% decline over 3 years and 7.9% over 5 years, which gives you a mixed picture of recent and longer term performance. Recent coverage around American States Water has focused on it as a...

If you are wondering whether Wendy's current share price really reflects what the business is worth, this breakdown will help you connect the recent moves in the stock to what the underlying valuation signals are saying. The share price recently closed at US$7.06, with returns of 2.3% over 7 days, a 2.9% decline over 30 days, a 13.6% decline year to date, and a 42.8% decline over the past year, which may have shifted how investors view both risk and potential upside. Recent coverage around...

Land & Buildings has escalated its activist campaign at First Industrial Realty Trust (NYSE:FR), urging shareholders to vote against the re-election of the current Chairman and a long-serving director at the upcoming annual meeting. The activist investor argues that recent actions by FR, including a share buyback, dividend increase, and addition of a new director, do not fully address what it views as ongoing governance and valuation concerns. Land & Buildings is calling for substantial...

If you are wondering whether Biogen's current share price reflects its true worth, you are not alone. Many investors are asking whether the stock still offers value after its recent moves. The stock last closed at US$179.90, with a 1 year return of 49.3% but also shorter term moves of a 2.1% decline over 7 days, a 4.4% decline over 30 days, and a modest 1.2% gain year to date. These shifts can change how the market views both its growth potential and risk. Recent news flow around Biogen has...

Wondering whether PTC at around US$144 per share offers real value or just noise? This article walks through what the current price may be implying about the business. The stock is up 1.3% over the last 7 days, even though it shows a 11.7% decline over 30 days and a 15.2% decline year to date, with a 3.3% decline over the past year and a 14.2% return over three years. These mixed returns put extra focus on what has been moving sentiment around PTC recently, as investors react to new...

Virgin Galactic Holdings recently filed a US$1.35 million shelf registration for 555,000 shares tied to its employee stock plan and reported fourth-quarter 2025 sales of US$312,000 alongside a net loss of US$62.72 million. At the same time, the company has reopened US$750,000-per-seat ticket sales and advanced its Delta-class spacecraft toward testing, highlighting a push to align capital, talent and product readiness ahead of a planned return to commercial service. We’ll now examine how the...

Mid-America Apartment Communities (MAA) is back in focus as analysts update their views, the REIT prepares to report upcoming earnings, and insiders execute planned share sales alongside a recently confirmed quarterly dividend. See our latest analysis for Mid-America Apartment Communities. The recent 1-day share price return of 1.44% and 7-day gain of 2.89% to US$126.09 sit against a weaker backdrop, with a 30-day share price return of 4.58% and a 1-year total shareholder return of 16.66%...

Why Stepan Stock Is Back on Investors’ Radar Stepan (SCL) has drawn fresh attention after its recent share move, with the stock closing at $51.55 and short term returns over the past week and month turning positive. See our latest analysis for Stepan. The recent 1 month share price return of 7.44% and year to date share price return of 9.31% contrast with a 5 year total shareholder return decline of 55.97%, which suggests momentum has only recently started to improve. If Stepan’s rebound has...

Kura Sushi USA (KRUS) opened Q2 2026 with revenue of US$80.0 million, a basic EPS loss of US$0.14, and net income loss of US$1.7 million, setting the tone for another quarter where top line growth is front and center while profitability remains under pressure. The company has reported quarterly revenue increasing from US$64.9 million in Q2 2025 to US$80.0 million in Q2 2026, while basic EPS moved from a loss of US$0.31 to a loss of US$0.14 over the same period, alongside a trailing twelve...

BeOne Medicines recently received FDA Orphan Drug Designation for its lead hepatocellular carcinoma candidate, while research firms initiated and adjusted coverage highlighting its broad oncology program and flagship therapy Brukinsa. This combination of regulatory recognition and shifting analyst views underscores how expectations for BeOne’s pipeline and commercialization efforts are being actively reassessed by the market. Next, we’ll examine how the new FDA Orphan Drug Designation could...

AI runs on real world hardware, and right now that physical backbone is where a lot of the attention is going. While energy prices, interest rate expectations, and geopolitical tensions are keeping many sectors on edge, the companies building data centers, power connections, and cooling systems are dealing in tangible demand. The AI Infrastructure Stocks screener focuses on those providers that are turning sales into cash flow, instead of just selling a story. In this article, you will see 3...

In recent months, hedge funds such as Duquesne Capital have been increasing their positions in BBB Foods Inc. (NYSE:TBBB), while the company has expanded its Mexican grocery footprint by opening 574 net new stores during 2025. This combination of rising institutional ownership and rapid store rollout highlights how investors are focusing on BBB Foods’ potential to win customers from traditional mom-and-pop retailers through scale and private-label offerings. Next, we will examine how BBB...

NetApp (NasdaqGS:NTAP) and Nutanix have announced a new alliance to combine NetApp's Intelligent Data Infrastructure with the Nutanix Cloud Platform and hypervisor. The joint offering is designed for hybrid and multicloud environments, with capabilities for streamlined migration, simplified operations, VM level management, and built in cyber resilience. NetApp and Nutanix also plan deeper integration over time to support customers that are pursuing AI related use cases. For investors...

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...